Robert S. Kerbel

ScholarGPS® ID: 95091026928275

Affiliation
University of Toronto, Toronto, Canada
Affiliation History

Field
Life Sciences
Discipline
Biology and Biological Sciences
Top Specialties
Cancer | Neoplasm | Metastasis | Chemotherapy | Angiogenesis | Melanoma | Breast Cancer | Vascular Endothelial Growth Factor | Growth Factor | Cyclophosphamide | Antibody | Tumor Progression | Antigen | DNA | Drug Resistance
Metrics Summary
Publication Count
512
Predicted Citations
61,488
Predicted h-index
122
Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

  • Publications
  • Books
  • Patents
  • NIH/NSF
You must register and claim your profile to add or remove publications from it.
... publications
FILTER BY:
Year
Type
Specialty
Affiliations
Access
Co-Authors
Add
Delete
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials (journal article)
Kuo, Hung-Yang | Khan, Kabir A. | Kerbel, Robert S.
Nature Reviews Clinical Oncology, volume 21, issue 6, pages 468-482 (2024).
10.1038/s41571-024-00886-y
Cite | Source
ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth (journal article)
Liu, Xiaoyang | Chipurupalli, Sandhya | Jiang, Peijia | Tavasoli, Mahtab | Yoo, Byong Hoon | McPhee, Michael | Mazinani, Sina | Francia, Giulio | Kerbel, Robert S. | Rosen, Kirill V.
Cell Death & Disease, volume 13, issue 8 (2022).
10.1038/s41419-022-05117-9
Cited by (3) | Cite | Source
On coalescent angiogenesis and the remarkable flexibility of blood vessels (journal article)
Pezzella, Francesco | Kerbel, Robert S.
Angiogenesis, volume 25, issue 1, pages 1-3 (2022).
10.1007/s10456-021-09825-2
Cited by (5) | Cite | Source
Tumors resurrect an embryonic vascular program to escape immunity (journal article)
Huijbers, Elisabeth J. M. | Khan, Kabir A. | Kerbel, Robert S. | Griffioen, Arjan W.
Science Immunology, volume 7, issue 67 (2022).
10.1126/sciimmunol.abm6388
Cited by (30) | Cite | Source
Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer (journal article)
Khan, Kabir A | Wu, Florence TH | Cruz‐Munoz, William | Kerbel, Robert S
EMBO Molecular Medicine, volume 13, issue 7 (2021).
10.15252/emmm.201708253
Cited by (22) | Cite | Source
Adjuvant metronomic chemotherapy for locoregionally advanced nasopharyngeal carcinoma (journal article)
Kerbel, Robert S | Andre, Nicolas
The Lancet, volume 398, issue 10297, pages 278-279 (2021).
10.1016/S0140-6736(21)01240-X
Cited by (7) | Cite | Source
Dr. Isaiah “Josh” Fidler, 1936–2020: A Fond Remembrance (journal article)
Kerbel, Robert
Neoplasia, volume 22, issue 11, pages 604-605 (2020).
10.1016/j.neo.2020.08.003
Cite | Source
Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers (journal article)
Schito, Luana | Rey, Sergio | Xu, Ping | Man, Shan | Cruz‐Muñoz, William | Kerbel, Robert S
EMBO Molecular Medicine, volume 12, issue 9 (2020).
10.15252/emmm.201911416
Cited by (21) | Cite | Source
Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer (journal article)
Khan, Kabir A. | Ponce de Léon, José L. | Benguigui, Madeleine | Xu, Ping | Chow, Annabelle | Cruz-Muñoz, William | Man, Shan | Shaked, Yuval | Kerbel, Robert S.
npj Breast Cancer, volume 6, issue 1 (2020).
10.1038/s41523-020-0171-1
Cited by (25) | Cite | Source
A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis (journal article)
Khan, Kabir A | Kerbel, Robert S
EMBO Molecular Medicine, volume 12, issue 6 (2020).
10.15252/emmm.202012355
Cited by (6) | Cite | Source
Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1 (journal article)
Timaner, Michael | Kotsofruk, Ruslana | Raviv, Ziv | Magidey, Ksenia | Shechter, Dvir | Kan, Tal | Nevelsky, Alexander | Daniel, Shahar | de Vries, Elisabeth G. E. | Zhang, Tongwu | ... | Shaked, Yuval
Oncogene, volume 39, issue 1, pages 187-203 (2020).
10.1038/s41388-019-0971-7
Cited by (36) | Cite | Source
Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer (journal article)
Reguera-Nuñez, Elaine | Xu, Ping | Chow, Annabelle | Man, Shan | Hilberg, Frank | Kerbel, Robert S.
Journal of Experimental & Clinical Cancer Research, volume 38, issue 1 (2019).
10.1186/s13046-018-0999-5
Cited by (28) | Cite | Source
Variable impact of three different antiangiogenic drugs alone or in combination with chemotherapy on multiple bone marrow-derived cell populations involved in angiogenesis and immunity (journal article)
Reguera-Nuñez, Elaine | Man, Shan | Xu, Ping | Hilberg, Frank | Kerbel, Robert S.
Angiogenesis, volume 22, issue 4, pages 535-546 (2019).
10.1007/s10456-019-09677-x
Cited by (3) | Cite | Source
Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion (journal article)
Muñoz, Raquel | Hileeto, Denise | Cruz-Muñoz, William | Wood, Geoffrey A. | Xu, Ping | Man, Shan | Viloria-Petit, Alicia | Kerbel, Robert S.
PLOS ONE, volume 14, issue 9, pages e0222580- (2019).
10.1371/journal.pone.0222580
Cited by (6) | Cite | Source
Vessel co-option in cancer (journal article)
Kuczynski, Elizabeth A. | Vermeulen, Peter B. | Pezzella, Francesco | Kerbel, Robert S. | Reynolds, Andrew R.
Nature Reviews Clinical Oncology, volume 16, issue 8, pages 469-493 (2019).
10.1038/s41571-019-0181-9
Cited by (284) | Cite | Source
Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents (journal article)
Miller, Ian S. | Shiels, Liam P. | Conroy, Emer | Connor, Kate | Dicker, Patrick | Gallagher, William M. | Donovan, Norma O’ | Kerbel, Robert S. | Crown, John | Byrne, Annette T.
Scientific Reports, volume 9, issue 1 (2019).
10.1038/s41598-019-45444-0
Cited by (4) | Cite | Source
Blood vessels and cancer (book chapter)
In Oxford Textbook of Cancer Biology
Pezzella, Francesco | Kerbel, Robert
Oxford University Press (2019)
10.1093/med/9780198779452.003.0022
Cite | Source
Personalized use of metronomic cyclophosphamide for DNA repair deficient castration-resistant prostate cancer: A phase II trial. (journal article)
Phillips, Cameron | Francia, Giulio | Kerbel, Robert S. | Emmenegger, Urban
Journal of Clinical Oncology, volume 37, issue 7_suppl, pages TPS346-TPS346 (2019).
10.1200/JCO.2019.37.7_suppl.TPS346
Cite | Source
Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease (journal article)
Wu, Florence T. H. | Xu, Ping | Chow, Annabelle | Man, Shan | Krüger, Janna | Khan, Kabir A. | Paez-Ribes, Marta | Pham, Elizabeth | Kerbel, Robert S.
British Journal of Cancer, volume 120, issue 2, pages 196-206 (2019).
10.1038/s41416-018-0297-1
Cited by (30) | Cite | Source
Preclinical impact of high dose intermittent antiangiogenic tyrosine kinase inhibitor pazopanib in intrinsically resistant tumor models (journal article)
Reguera-Nuñez, Elaine | Man, Shan | Xu, Ping | Kerbel, Robert S.
Angiogenesis, volume 21, issue 4, pages 793-804 (2018).
10.1007/s10456-018-9623-8
Cited by (5) | Cite | Source